Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemiaP A Cassileth, D P Harrington, J D Hines, et al.
Leukemia & Lymphoma|August 26, 1998
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)P H Wiernik, D F Moore, J M Bennett, et al.
Cancer|January 15, 1980
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adultsR T Skeel, W Costello, J M Bennett, et al.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell diseaseF J Cummings, K Kim, R S Neiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
American Journal of Hematology|August 10, 1999
Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486M C Trendle, T Leong, R A Kyle, et al.
Blood|August 1, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group TrialH M Lazarus, J Andersen, M G Chen, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemiaP A Cassileth, D P Harrington, J D Hines, et al.
Leukemia & Lymphoma|August 26, 1998
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)P H Wiernik, D F Moore, J M Bennett, et al.
Cancer|January 15, 1980
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adultsR T Skeel, W Costello, J M Bennett, et al.
Cancer|September 24, 1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486M M Oken, T Leong, R E Lenhard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell diseaseF J Cummings, K Kim, R S Neiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
American Journal of Hematology|August 10, 1999
Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486M C Trendle, T Leong, R A Kyle, et al.
Blood|August 1, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group TrialH M Lazarus, J Andersen, M G Chen, et al.
Pageof 15